MDSCs are primarily generated in the bone marrow, and upon migrating to the tumor site, they can differentiate into immunosuppressive macrophages through the activation of the transcription factor NF-κB by S100A8/A9 proteins [67]. Here, IGKV1D-22 is linked to neoplasm.